Angiomotin and its role in breast cancer
Author Information
Author(s): Jiang Wen G, Watkins Gareth, Douglas-Jones Anthony, Holmgren Lars, Mansel Robert E
Primary Institution: Wales College of Medicine, Cardiff University
Hypothesis
This study examines the expression of angiomotin and its analogues in breast tumour tissues and their correlation with angiogenesis and clinical outcomes.
Conclusion
Angiomotin is highly expressed in human breast tumour tissues and is linked to angiogenesis and the aggressive nature of breast tumours.
Supporting Evidence
- Breast cancer tissues expressed significantly higher levels of angiomotin compared to normal mammary tissues.
- Angiomotin levels were higher in grade 2 and grade 3 tumours compared to grade 1.
- High levels of angiomotin were associated with shorter overall survival.
Takeaway
Angiomotin is a protein that helps blood vessels grow, and when it's found in high amounts in breast cancer, it can mean the cancer is more aggressive.
Methodology
The study used reverse transcription PCR to measure angiomotin levels in breast tissues and assessed microvessel density using specific antibodies.
Participant Demographics
The study included 120 breast cancer patients and 32 normal tissue samples.
Statistical Information
P-Value
p = 0.003
Confidence Interval
95% CI: 105.2–134.7
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website